Cargando…

Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy

BACKGROUND: BK polyomavirus‐associated nephropathy (BKPyVAN) carries a risk of irreversible allograft injury. While detection of BK viremia and biopsy assessment are the current diagnostic gold standard, the diagnostic value of biomarkers reflecting tissue injury (donor‐derived cell‐free DNA [dd‐cfD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayer, Katharina A., Omic, Haris, Weseslindtner, Lukas, Doberer, Konstantin, Reindl‐Schwaighofer, Roman, Viard, Thierry, Tillgren, Amanda, Haindl, Susanne, Casas, Silvia, Eskandary, Farsad, Heinzel, Andreas, Kozakowski, Nicolas, Kikić, Željko, Böhmig, Georg A., Eder, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078585/ https://www.ncbi.nlm.nih.gov/pubmed/35894263 http://dx.doi.org/10.1111/ctr.14785

Ejemplares similares

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival
por: Eder, Michael, et al.
Publicado: (2020)

Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
por: Omić, Haris, et al.
Publicado: (2022)

Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
por: Borski, Anita, et al.
Publicado: (2022)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
por: Mayer, Katharina A., et al.
Publicado: (2022)

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
por: Mühlbacher, Jakob, et al.
Publicado: (2020)

Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial
por: Doberer, Konstantin, et al.
Publicado: (2020)

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients
por: Strassl, Robert, et al.
Publicado: (2019)

Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial
por: Doberer, Konstantin, et al.
Publicado: (2021)

High-activity Classical and Alternative Complement Pathway Genotypes—Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
por: Mező, Blanka, et al.
Publicado: (2020)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
por: Regele, Florina, et al.
Publicado: (2022)

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients
por: Strassl, Robert, et al.
Publicado: (2018)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2021)

Lessons from Polyomavirus Immunofluorescence Staining of Urinary Decoy Cells
por: Pajenda, Sahra, et al.
Publicado: (2023)

Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
por: Vietzen, Hannes, et al.
Publicado: (2022)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
por: Stiasny, Karin, et al.
Publicado: (2022)

Role of BK human polyomavirus in cancer
por: Levican, Jorge, et al.
Publicado: (2018)

BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes
por: Küssel, Lorenz, et al.
Publicado: (2017)

Renal allograft DARCness in subclinical acute and chronic active ABMR
por: Kläger, Johannes, et al.
Publicado: (2021)

BK Polyomavirus—Biology, Genomic Variation and Diagnosis
por: Furmaga, Jacek, et al.
Publicado: (2021)

BK Polyomavirus-Induced Nephropathy in Native Kidney
por: Munjal, Ripudaman S, et al.
Publicado: (2023)

BK polyomavirus: latency, reactivation, diseases and tumorigenesis
por: Zhou, Xianfeng, et al.
Publicado: (2023)

Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease
por: Eder, Michael, et al.
Publicado: (2021)

Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication—a retrospective study
por: Weseslindtner, Lukas, et al.
Publicado: (2020)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Markers of potassium homeostasis in salt losing tubulopathies- associations with hyperaldosteronism and hypomagnesemia
por: Eder, Michael, et al.
Publicado: (2020)

Molecular Networks Involved in the Immune Control of BK Polyomavirus
por: Girmanova, Eva, et al.
Publicado: (2012)

Polyomavirus BK and prostate cancer: an unworthy scientific effort?
por: Delbue, Serena, et al.
Publicado: (2014)

BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches
por: Lamarche, Caroline, et al.
Publicado: (2016)

Prevalence of Human Polyomavirus JC and BK in Normal Population
por: Karimi Dehcheshmeh, Lila, et al.
Publicado: (2020)

Urine Donor–Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection
por: Chen, Xu-Tao, et al.
Publicado: (2020)

Genome Sequence of a Central Chimpanzee-Associated Polyomavirus Related to BK and JC Polyomaviruses, Pan troglodytes troglodytes Polyomavirus 1
por: Madinda, Nadège F., et al.
Publicado: (2015)

Neutralization Serotyping of BK Polyomavirus Infection in Kidney Transplant Recipients
por: Pastrana, Diana V., et al.
Publicado: (2012)

Entry Tropism of BK and Merkel Cell Polyomaviruses in Cell Culture
por: Schowalter, Rachel M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nhqortkd8te1dcsr6e078i2ajb